LRMR – larimar therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Wedbush Raises its Price Target on Larimar Therapeutics (LRMR) to $13 [Yahoo! Finance]
Larimar Therapeutics (LRMR) was upgraded by Truist Financial Corporation to "strong-buy".
Larimar Therapeutics (LRMR) had its price target raised by Wedbush from $12.00 to $13.00. They now have an "outperform" rating on the stock.
Larimar Therapeutics GAAP EPS of -$0.73 misses by $0.22 [Seeking Alpha]
Larimar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Form ARS Larimar Therapeutics, For: Dec 31
Form DEF 14A Larimar Therapeutics, For: Apr 17
Form PRE 14A Larimar Therapeutics, For: May 19
Form S-8 Larimar Therapeutics,
Form 10-K Larimar Therapeutics, For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.